Skip to main content
. 2019 May 1;76(8):854–861. doi: 10.1001/jamapsychiatry.2019.0801

Figure 1. Dopamine Transporter (DAT) Availability in Major Depressive Disorder (MDD).

Figure 1.

Age-residualized DAT availability (as assessed by binding potential [BPND]) in the healthy control (HC; n = 23) and MDD (n = 25) groups for striatal regions (A) and the ventral tegmental area (VTA) (B).

aP < .05.